5251 - 5260 of 6403 Results
Title
Year
-
OPENTitle: Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratoriesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00491-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00491-yCitation Count: 50
-
OPENTitle: Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 10Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.338Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.338Citation Count: 479
-
OPENTitle: Care access and utilization among medicare beneficiaries living with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00523-yBest OA location URL: https://www.nature.com/articles/s41531-023-00523-y.pdfCitation Count: 23
-
OPENTitle: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagyJournal Name: SLAS DiscoveryPublisher: Elsevier BVVol: 28Issue #: 3Start Page: 73End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004Best OA location URL: http://slas-discovery.org/article/S2472555222137160/pdfCitation Count: 11
-
OPENTitle: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient miceJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 4Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci.insight.126769Best OA location URL: https://doi.org/10.1172/jci.insight.126769Citation Count: 22
-
OPENTitle: Cortical disinhibition in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 11Start Page: 3408End Page: 3421Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa274Best OA location URL: http://hdl.handle.net/11268/11191Citation Count: 68
-
OPENTitle: A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progressionJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43587-025-00926-xBest OA location URL: https://www.nature.com/articles/s43587-025-00926-x.pdfCitation Count: 0
- miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems2020OPENTitle: miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systemsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 48Issue #: W1Start Page: W521End Page: W528Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1093/nar/gkaa309Best OA location URL: https://academic.oup.com/nar/article-pdf/48/W1/W521/33433413/gkaa309.pdfCitation Count: 168
-
OPENTitle: Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation ProgramJournal Name: NeuropathologyPublisher: WileyVol: 35Issue #: 4Start Page: 354End Page: 389Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/neup.12189Best OA location URL: http://doi.org/10.1111/neup.12189Citation Count: 427
-
OPENTitle: Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex VivoJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page: 794End Page: 800Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11481-020-09909-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-020-09909-8.pdfCitation Count: 19